Patents by Inventor Joerg Meil

Joerg Meil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5952327
    Abstract: Compounds having NEP-inhibitory activity, corresponding to the formula I in whichR.sup.1 is hydrogen or a group forming a biolabile phosphonic acid ester,R.sup.2 is hydrogen or a group forming a biolabile phosphonic acid ester andR.sup.3 is hydrogen or a group forming a biolabile carboxylic acid esterand physiologically acceptable salts of acids of formula I, and pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: September 14, 1999
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Harald Waldeck, Joerg Meil, Dirk Thormaehlen, Michael Wurl
  • Patent number: 5532251
    Abstract: The use of 3-benzoyl-3,7-diazabicyclo[3.3.1]nonane compounds of the general formula I ##STR1## in which R.sup.1 is an alkyl group having 1-6 carbon atoms or a cycloalkylalkyl group having 4-7 carbon atoms,R.sup.2 and R.sup.3 are each individually lower alkyl or together form an alkylene chain having 3-6 carbon atoms,R.sup.4 is hydrogen, halogen, cyano, nitro, trifluoromethyl or a R.sup.6 --SO.sub.2 -- group, in which R.sup.6 is fluorine or lower alkyl, andR.sup.5 is hydrogen, halogen, trifluoromethyl or nitro, or their physiologically acceptable acid addition salts for the treatment of cardiac arrhythmias in larger mammals, including humans.
    Type: Grant
    Filed: February 1, 1995
    Date of Patent: July 2, 1996
    Assignee: Kali-Chemie Pharma GmbH
    Inventors: Uwe Schoen, Reinhard Brueckner, Joerg Meil, Dirk Thormaehlen